Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crossing paths: historical and philosophical perspectives on cancer and diabetes classifications.

History and philosophy of the life sciences·2026
Same author

Birth weight of term born offspring in relation to long-term maternal cardiovascular morbidity and mortality.

European journal of epidemiology·2026
Same author

Metabolic Perturbations and Ectopic Fat Deposition in Men With Low Birth Weight: Effects of a 4-Week Carbohydrate Overfeeding Challenge.

Diabetes·2025
Same author

Societal and biological approaches to diabetes prevention and care for Inuit populations: a narrative review.

Diabetologia·2025
Same author

The interplay between birth weight and obesity in determining childhood and adolescent cardiometabolic risk.

EBioMedicine·2024
Same author

Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3).

Diabetic medicine : a journal of the British Diabetic Association·2024

Related Experiment Video

Updated: Sep 11, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K

Actionability of Genetic Variants in Diabetes: Core Aspects and Applied Examples.

Sarah Yvonnet1,2, Pauline Kromann Reim2, Anne Cathrine Baun Thuesen2

  • 1Medical Museion, Department of Public Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Diabetes Spectrum : a Publication of the American Diabetes Association
|August 18, 2025
PubMed
Summary

Precision medicine for diabetes requires clear criteria for actionable genetic variants. This study proposes a framework to bridge the gap between genomic research and clinical practice for diabetes treatment.

More Related Videos

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.5K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.8K

Related Experiment Videos

Last Updated: Sep 11, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.5K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.8K

Area of Science:

  • Genetics
  • Philosophy of Medicine
  • Biomedical Science

Background:

  • Diabetes classification (type 1, type 2) is insufficient for its complex, heterogeneous nature.
  • Genomic technologies offer potential for precision diabetes medicine, but clinical implementation faces challenges.
  • The concept of 'actionability' for genetic variants lacks a clear, cross-disciplinary definition.

Purpose of the Study:

  • To develop a framework for assessing the actionability of genetic variants in diabetes.
  • To bridge the translational gap between diabetes genomic research and clinical practice.
  • To define criteria for when genetic variants are actionable in diabetes management.

Main Methods:

  • Collaborative effort between philosophy of medicine and biomedical science.
  • Review of scientific, medical, and philosophical literature on genetic actionability.
  • Case study analysis to evaluate actionability in diabetes treatment and management.

Main Results:

  • Identified core aspects of actionability for genetic variants in diabetes.
  • Highlighted tensions between research and clinical practice regarding genetic data.
  • Evaluated the challenges in translating genetic discoveries into actionable clinical insights for diabetes.

Conclusions:

  • A robust framework is needed to define and assess genetic variant actionability in diabetes care.
  • Bridging the research-to-practice gap is crucial for realizing precision medicine in diabetes.
  • Clear criteria for actionability will improve diagnostic accuracy and treatment strategies for diabetes.